WEIGHING IN: ACTUAL VS IDEAL VS ADJUSTED BODY WEIGTH TO CALCULATE DOSE OF MELPHALAN IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Kopp, Michelle [1 ]
Talamo, Giampaolo [1 ]
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
来源：
ONCOLOGY NURSING FORUM | 2015年 / 42卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
38
引用
收藏
页码：E155 / E155
页数：1
相关论文
共 50 条
  • [11] The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning
    Ursu, Sorana G.
    Maples, Samantha
    Williams, Kiersten J.
    Patrus, Gina
    Samhouri, Yazan
    Fazal, Salman
    Mewawalla, Prerna
    Sadashiv, Santhosh
    JOURNAL OF HEMATOLOGY, 2023, 12 (05) : 201 - 207
  • [12] Single daily dose of intravenous busulfan and melphalan as conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation
    de la Rubia, J.
    Lahuerta, J.
    Gonzalez, J.
    Solano, C.
    Rivas, P.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S323 - S323
  • [13] The effect of melphalan administration time on engraftment in multiple myeloma patients undergoing autologous stem cell transplantation
    Unal, Ali
    Yildizhan, Esra
    Kaynar, Leylagul
    Varal, Fatma
    Ciftci, Sibel
    Coskun, Elmas
    Yildiz, Gulseren
    Yanar, Ayse
    Eser, Bulent
    Cetin, Mustafa
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 293
  • [14] Melphalan vs Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) As Preparative Regimen for Newly Diagnosed Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
    Namburi, Swathi
    Bailey, Megumi
    Tsomo, Tenzin
    Neil, Bailey
    Lu, Chiachun
    Egan, Daniel
    Patel, Krish
    Bensinger, William
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S238 - S238
  • [15] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [16] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [17] REDUCED-DOSE MELPHALAN VS. STANDARD DOSE MELPHALAN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION: IS THERE A DIFFERENCE IN OUTCOME?
    Maewal, I
    Gulbis, A.
    Champlin, R. E.
    Qazilbash, M. H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S376 - S377
  • [18] Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age
    D E Reece
    C Bredeson
    W S Pérez
    S Jagannath
    M J Zhang
    K K Ballen
    G J Elfenbein
    C O Freytes
    R P Gale
    M A Gertz
    J Gibson
    S A Giralt
    A Keating
    R A Kyle
    D Maharaj
    D Marcellus
    P L McCarthy
    G A Milone
    S D Nimer
    S Pavlovsky
    L B To
    D J Weisdorf
    P H Wiernik
    J R Wingard
    D H Vesole
    Bone Marrow Transplantation, 2003, 32 : 1135 - 1143
  • [19] Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma
    Shah, Nina
    Cornelison, A. Megan
    Saliba, Rima
    Ahmed, Sairah
    Nieto, Yago L.
    Bashir, Qaiser
    Parmar, Simrit
    Hosing, Chitra
    Popat, Uday
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (06) : 532 - 535
  • [20] PHARMACOKINETICS AND PHARMACODYNAMICS OF HIGH DOSE MELPHALAN IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT.
    Cho, Y.
    Wang, J.
    Gao, Y.
    Li, J.
    Lamprecht, M.
    Jukich, M.
    Schaaf, L. J.
    Poi, M.
    Hofmeister, C. C.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S38 - S38
12345